This week saw two $250 million-plus initial public offering (IPO) filings for Neumora Therapeutics and RayzeBio, plus a record third-round financing for Generate Biomedicines - further evidence that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results